SPRINGWORKS THERAPEUTICS, INC. (SWTX): Price and Financial Metrics
SWTX Price/Volume Stats
| Current price | $36.34 | 52-week high | $53.92 |
| Prev. close | $36.35 | 52-week low | $28.21 |
| Day low | $35.39 | Volume | 754,929 |
| Day high | $36.93 | Avg. volume | 1,000,029 |
| 50-day MA | $35.84 | Dividend yield | N/A |
| 200-day MA | $38.70 | Market Cap | 2.70B |
SWTX Stock Price Chart Interactive Chart >
SPRINGWORKS THERAPEUTICS, INC. (SWTX) Company Bio
Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
SWTX Price Returns
| 1-mo | -12.39% |
| 3-mo | 12.79% |
| 6-mo | -2.52% |
| 1-year | -0.44% |
| 3-year | -41.37% |
| 5-year | N/A |
| YTD | -0.44% |
| 2023 | 40.33% |
| 2022 | -58.03% |
| 2021 | -14.53% |
| 2020 | 88.41% |
| 2019 | N/A |
Loading social stream, please wait...